HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ledwith, B. J. Articles by Manam, S. Search for Related Content PubMed PubMed Citation Articles by Ledwith, B. J. Articles by Manam, S. Social Bookmarking                      What's this?

Volume 272, Number 6, Issue of February 7, 1997 pp. 3707-3714
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver Cells

(Received for publication, May 24, 1996, and in revised form, October 24, 1996)

From the Department of Genetic and Cellular Toxicology and ^§ Department of Biochemical Toxicology, Merck Research Laboratories, West Point, Pennsylvania 19486

Increased expression of cyclooxygenase-2 (COX-2), the rate-limiting enzyme in prostaglandin synthesis, has been associated with growth regulation and carcinogenesis in several systems. COX-2 is known to be induced by cytokines and the skin tumor promoter 12-tetradecanoylphorbol-13-myristate (TPA). In the present study, we investigated the effects of several non-TPA-type tumor promoters on COX-2 expression in immortalized mouse liver cells. Specifically, we tested peroxisome proliferators (PPs), which are rodent liver tumor promoters that cause gross alterations in cellular lipid metabolism, the rodent liver tumor promoter phenobarbital, and the skin tumor promoters okadaic acid and thapsigargin. The PPs Wy-14643, mono-ethylhexyl phthalate, clofibrate, ciprofibrate ethyl ester, and eicosatetraynoic acid each caused large increases in COX-2 mRNA and protein, with maximal expression seen approximately 10 h after treatment of quiescent cells. COX-2 expression was also induced by thapsigargin, okadaic acid, and calcium ionophore A23187, but not by phenobarbital or the steroid PP dehydroepiandrosterone sulfate. Induction of COX-2 expression generally resulted in increased synthesis of prostaglandin E₂ (PGE₂). However, the PPs caused little or no increase in PGE₂ levels, and they inhibited serum-induced PGE₂ synthesis. Unlike non-steroidal anti-inflammatory drugs, the PPs do not directly inhibit cyclooxygenase enzyme activity in vitro. Thus, PPs regulate prostaglandin metabolism via both positive (COX-2 induction) and inhibitory mechanisms. In summary, the strong induction of COX-2 expression by PPs, thapsigargin, and okadaic acid suggests a possible role for COX-2 in the growth regulatory activity of these non-TPA-type tumor promoters.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. M. Onorato, P. W. Brown, and P. L. Morris Mono-(2-ethylhexyl) Phthalate Increases Spermatocyte Mitochondrial Peroxiredoxin 3 and Cyclooxygenase 2 J Androl, May 1, 2008; 29(3): 293 - 303. [Abstract] [Full Text] [PDF]

				C. M. Holland, S. A. Saidi, A. L. Evans, A. M. Sharkey, J. A. Latimer, R. A.F. Crawford, D. S. Charnock-Jones, C. G. Print, and S. K. Smith Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets Mol. Cancer Ther., August 1, 2004; 3(8): 993 - 1001. [Abstract] [Full Text] [PDF]

				L. Pang, M. Nie, L. Corbett, and A. J. Knox Cyclooxygenase-2 Expression by Nonsteroidal Anti-inflammatory Drugs in Human Airway Smooth Muscle Cells: Role of Peroxisome Proliferator-Activated Receptors J. Immunol., January 15, 2003; 170(2): 1043 - 1051. [Abstract] [Full Text] [PDF]

				A. V. Pontsler, A. St. Hilaire, G. K. Marathe, G. A. Zimmerman, and T. M. McIntyre Cyclooxygenase-2 Is Induced in Monocytes by Peroxisome Proliferator Activated Receptor gamma and Oxidized Alkyl Phospholipids from Oxidized Low Density Lipoprotein J. Biol. Chem., April 5, 2002; 277(15): 13029 - 13036. [Abstract] [Full Text] [PDF]

				A. Denda, W. Kitayama, A. Murata, H. Kishida, Y. Sasaki, O. Kusuoka, T. Tsujiuchi, M. Tsutsumi, D. Nakae, H. Takagi, et al. Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide Carcinogenesis, February 1, 2002; 23(2): 245 - 256. [Abstract] [Full Text] [PDF]

				B. L. Diaz, H. Fujishima, Y. Kanaoka, Y. Urade, and J. P. Arm Regulation of Prostaglandin Endoperoxide Synthase-2 and IL-6 Expression in Mouse Bone Marrow-Derived Mast Cells by Exogenous But Not Endogenous Prostanoids J. Immunol., February 1, 2002; 168(3): 1397 - 1404. [Abstract] [Full Text] [PDF]

				V. de Ledinghen, H. Liu, F. Zhang, C. R. Lo, K. Subbaramaiah, A. J. Dannenberg, and M. J. Czaja Induction of cyclooxygenase-2 by tumor promoters in transformed and cytochrome P450 2E1-expressing hepatocytes Carcinogenesis, January 1, 2002; 23(1): 73 - 79. [Abstract] [Full Text] [PDF]

				V. Tsimihodimos, A. Kakafika, and M. Elisaf Fibrate treatment can increase serum creatinine levels Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1301 - 1301. [Full Text] [PDF]

				Y. J. Jiang, G. M. Hatch, D. Mymin, T. Dembinski, E. A. Kroeger, and P. C. Choy Modulation of cytosolic phospholipase A2 by PPAR activators in human preadipocytes J. Lipid Res., May 1, 2001; 42(5): 716 - 724. [Abstract] [Full Text]

				N. Broeders, C. Knoop, M. Antoine, C. Tielemans, and D. Abramowicz Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent? Nephrol. Dial. Transplant., December 1, 2000; 15(12): 1993 - 1999. [Abstract] [Full Text] [PDF]

				C.-J. Yuan, A. K. Mandal, Z. Zhang, and A. B. Mukherjee Transcriptional Regulation of Cyclooxygenase-2 Gene Expression: Novel Effects of Nonsteroidal Anti-Inflammatory Drugs Cancer Res., February 1, 2000; 60(4): 1084 - 1091. [Abstract] [Full Text]

				A. Bonazzi, V. Mastyugin, P. A. Mieyal, M. W. Dunn, and M. Laniado-Schwartzman Regulation of Cyclooxygenase-2 by Hypoxia and Peroxisome Proliferators in the Corneal Epithelium J. Biol. Chem., January 28, 2000; 275(4): 2837 - 2844. [Abstract] [Full Text] [PDF]

				D. Wolfle, S. Marotzki, D. Dartsch, W. Schafer, and H. Marquardt Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibenzo- p-dioxin Carcinogenesis, January 1, 2000; 21(1): 15 - 21. [Abstract] [Full Text] [PDF]

				T. B. Barclay, J. M. Peters, M. B. Sewer, L. Ferrari, F. J. Gonzalez, and E. T. Morgan Modulation of Cytochrome P-450 Gene Expression in Endotoxemic Mice Is Tissue Specific and Peroxisome Proliferator-Activated Receptor-alpha Dependent J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1250 - 1257. [Abstract] [Full Text]

				B. Kroll, S. Kunz, T. Klein, and L. R. Schwarz Effect of lindane and phenobarbital on cyclooxygenase-2 expression and prostanoid synthesis by Kupffer cells Carcinogenesis, August 1, 1999; 20(8): 1411 - 1416. [Abstract] [Full Text] [PDF]

				D. L. Simmons, R. M. Botting, P. M. Robertson, M. L. Madsen, and J. R. Vane Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs PNAS, March 16, 1999; 96(6): 3275 - 3280. [Abstract] [Full Text] [PDF]

				N. A. Callejas, A. Castrillo, and L. B. a. P. Martín-Sanz Inhibition of Prostaglandin Synthesis Up-Regulates Cyclooxygenase-2 Induced by Lipopolysaccharide and Peroxisomal Proliferators J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1235 - 1241. [Abstract] [Full Text]

				S. R. Adderley and D. J. Fitzgerald Oxidative Damage of Cardiomyocytes Is Limited by Extracellular Regulated Kinases 1/2-mediated Induction of Cyclooxygenase-2 J. Biol. Chem., February 19, 1999; 274(8): 5038 - 5046. [Abstract] [Full Text] [PDF]

				J. P. Vanden Heuvel Peroxisome Proliferator–Activated Receptors: A Critical Link among Fatty Acids, Gene Expression and Carcinogenesis J. Nutr., February 1, 1999; 129(2): 575 - 575. [Abstract] [Full Text] [PDF]

				P. R. Colville-Nash, S. S. Qureshi, D. Willis, and D. A. Willoughby Inhibition of Inducible Nitric Oxide Synthase by Peroxisome Proliferator-Activated Receptor Agonists: Correlation with Induction of Heme Oxygenase 1 J. Immunol., July 15, 1998; 161(2): 978 - 984. [Abstract] [Full Text] [PDF]

				S. L. Bursten, D. Federighi, J. Wald, B. Meengs, W. Spickler, and E. Nudelman Lisofylline Causes Rapid and Prolonged Suppression of Serum Levels of Free Fatty Acids J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 337 - 345. [Abstract] [Full Text]